Ranan DasGupta followed graduation from Cambridge University medical school, with a higher degree in Neuro-urology at Queen Square (UCL, London) and pioneering studies of sacral neuromodulation, medical cannabinoids, intravesical botulinum toxin and use of PDE5 inhibitors in neuropathic sexual dysfunction.
He also sub-specialised in Endourology, for which he is the clinical lead at Imperial College Healthcare (London). Based at the leading tertiary centre in west London, the department offers comprehensive stone management, both surgical and medical, with over two decades of experience in all treatment options. As the main cancer centre, his interest in upper tract urothelial cancer has been maintained, with studies of upper tract photodynamic therapy presented internationally.
Having published numerous peer-reviewed papers and contributed to several book chapters (and co-editing a textbook on Urinary Tract Infection), he has also been local Principal Investigator for several national research studies (TISU, PURE, UK ROPE), maintaining his interest in clinical and basic research; he is a reviewer for 5 journals. Selected as an examiner for both undergraduate (MBBS) and postgraduate (FRCS(Urol)) levels, he remains committed to maintenance of educational standards.